C3 Awards Research Grant to Dr. Jaakko Sarparanta to Investigate Relationship Between Calpain 3 Activity and the Protein Titin

C3 SUPPORTS RESEARCH GROUP FOR NEUROMUSCULAR DISEASES

Coalition to Cure Calpain 3 (C3) is pleased to announce that a research grant has been awarded to Dr. Jaakko Sarparanta, researcher at the Research Group for Neuromuscular Diseases led by Dr. Bjarne Udd at Folkhälsan Research Center and Department of Medical Genetics, University of Helsinki, Finland. The project, titled “CAPN3-mediated proteolytic processing of C-terminal titin and turnover of titin fragments,” investigates the relationship between calpain 3 activity and the protein titin.

WHY TITIN MATTERS TO THOSE LIVING WITH LGMD2A

Titin is a large protein that functions as a molecular spring in muscle cells. It has recently been shown that calpain 3, the protein that is associated with LGMD2A (a form of calpainopathy), can cut titin, a protein that is associated with several muscle diseases including LGMD2J (a form of titinopathy). However, the physiological importance of this cleavage activity is unknown. Further, the fate of the resulting titin fragments is unclear. Dr. Sarparanta aims to understand the physiological role of calpain 3 in cutting titin and how dysfunction of this activity may lead to muscle disease.

Dr. Sarparanta states that the interplay of titin and calpain 3 is an intriguing topic. Although calpain 3 has been long known to bind titin at several sites, the functions of these multiple interactions are not well understood. Furthermore, the interaction in the M-band of the sarcomere, where the identified titin processing takes place, has not been studied extensively. Importantly, Dr. Sarparanta adds, “We believe this part of titin plays a role in the regulation of calpain 3 in the entire muscle fiber.”

C3 SCIENTIFIC DIRECTOR WEIGHS IN

C3 Scientific Director Dr. Jennifer Levy notes, “The biological roles of calpain 3 in muscle are still not fully understood. We are excited to fund Dr. Sarparanta’s project, which will contribute to our knowledge of what calpain 3 does in healthy muscle. A greater understanding of calpain 3’s role in muscle may lead to the identification of new pathways that could be targeted when developing therapies for LGMD2A.”

Recent Posts

  • Ruby Goldstein de Salazar Awarded C3 Travel Grant

    C3 awarded a Travel Grant to Ruby Goldstein de Salazar, a graduate student in Dr. Melissa Spencer’s laboratory at the University of California Los Angeles. Ms. Goldstein de Salazar traveled to Hiroshima, Japan in September 2026 to present her research at the 31st annual Congress of the World Muscle Society. Ms. Goldstein de Salazar’s presentation,... Read More
  • Djunda Ratenan-Peltier Awarded C3 Travel Grant

    C3 is pleased to announce that Djunda Ratenan-Peltier was awarded a Travel Grant for the presentation of her research at the international conference New Directions in Biology and Disease of Skeletal Muscle, which took place from June 7 to 10, 2026 in Fort Lauderdale, Florida. Ms. Ratenan-Peltier is a PhD student in Life Sciences at... Read More